ONCOZ.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 11:22):

Stats
Today's Volume	18 193.00
Average Volume	44 124.00
Market Cap	50.31M
EPS	SEK-0.357 ( 2023-10-31 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-2.90
ATR14	SEK0.0800 (1.86%)

OncoZenge AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OncoZenge AB (publ) Financials

Annual	2023
Revenue:	SEK3 000.00
Gross Profit:	SEK3 000.00 (100.00 %)
EPS:	SEK-1.360

Q4	2023
Revenue:	SEK0
Gross Profit:	SEK0 (0.00 %)
EPS:	SEK-0.270

Q3	2023
Revenue:	SEK0
Gross Profit:	SEK0 (0.00 %)
EPS:	SEK-0.360

Q2	2023
Revenue:	SEK0
Gross Profit:	SEK0 (0.00 %)
EPS:	SEK-0.380

Financial Reports:

No articles found.

OncoZenge AB (publ)

OncoZenge AB (publ), a pharmaceutical company, develops healthcare products for cancer supportive care. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden. OncoZenge AB (publ) is a subsidiary of Moberg Pharma AB (publ).